Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 19 December, 2019

Verseon Corporation

Discontinuation of Brokerage Accounts

RNS Number : 4521X
Verseon Corporation
19 December 2019

December 19, 2019

Verseon Corporation

("Verseon" or the "Company")

Discontinuation of Brokerage Accounts and Return of Share Certificates

Fremont, Calif.-Verseon, a clinical-stage pharmaceutical company, today announces that following the cancellation of AIM admission of its Common Shares, which has taken effect on December 19, 2019, the Company will no longer support brokerage accounts.

Any brokers holding Verseon Common Shares are required to send information regarding their clients' shareholdings to the Company by 5:00 p.m. PST on December 30, 2019 (the "Reporting Date"). Information is to be reported to the Company at [email protected] and includes names, contact information, and size of shareholding as reflected at close of business on December 18, 2019 by the accounts of the Company's registrar, Computershare Investor Services PLC. The Company will then issue new share certificates directly to the shareholders. Shareholders are advised to contact their broker at their earliest convenience to ensure their shareholdings and contact details are accurately reported. Brokers can contact the Company at [email protected] with any questions.

Any shareholders who currently hold Verseon Common Shares directly are required to send their share certificates, along with their name and contact information, to the Company by registered mail (c/o Investor Relations, 47071 Bayside Parkway, Fremont, CA 94538, USA) to be received by the Reporting Date. The Company will then issue new share certificates to the shareholders. Shareholders can contact the Company at [email protected] with any questions.

Brokers and shareholders who wish to report the required information prior to the Reporting Date are free to do so. Shareholders who do not turn in their certificates at this time are likely to experience delays in any future transactions, and may be required to deliver a medallion signature guarantee and additional indemnity insurance at the time of such transaction. In order to avoid these possible delays, shareholders are requested to return their certificates along with the requested information on or before the Reporting Date.

- Ends -

For further information, please contact

Verseon Corporation

[email protected]

+1 (510) 225 9022



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t